Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,436 | 729 | 40.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,500 | 9 | 34.6% |
| Travel and Lodging | $13,577 | 41 | 21.8% |
| Consulting Fee | $1,635 | 3 | 2.6% |
| Education | $77.44 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16,370 | 69 | $0 (2024) |
| Medtronic Vascular, Inc. | $11,516 | 79 | $0 (2020) |
| Abbott Laboratories | $9,760 | 136 | $0 (2024) |
| Chiesi USA, Inc. | $7,161 | 9 | $0 (2018) |
| ABIOMED | $2,085 | 14 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $2,079 | 31 | $0 (2023) |
| Impulse Dynamics (USA) Inc. | $1,502 | 38 | $0 (2024) |
| ARALEZ PHARMACEUTICALS US INC. | $1,203 | 5 | $0 (2018) |
| Amgen Inc. | $948.63 | 53 | $0 (2024) |
| The Spectranetics Corporation | $947.68 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,674 | 129 | Abbott Laboratories ($1,245) |
| 2023 | $5,492 | 138 | Abbott Laboratories ($2,577) |
| 2022 | $4,418 | 120 | Abbott Laboratories ($2,209) |
| 2021 | $1,824 | 61 | Abbott Laboratories ($871.76) |
| 2020 | $878.68 | 36 | Medtronic Vascular, Inc. ($274.52) |
| 2019 | $6,533 | 89 | Medtronic Vascular, Inc. ($4,484) |
| 2018 | $16,955 | 97 | Novartis Pharmaceuticals Corporation ($5,422) |
| 2017 | $21,449 | 114 | Novartis Pharmaceuticals Corporation ($10,085) |
All Payment Transactions
784 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 12/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/05/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $13.84 | General |
| 12/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $136.83 | General |
| Category: Heart Failure | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 11/22/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 11/19/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $6.29 | General |
| Category: Coronary | ||||||
| 11/08/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $34.41 | General |
| Category: Heart Failure | ||||||
| 11/08/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Heart Failure | ||||||
| 11/06/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $44.80 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/31/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $101.19 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/30/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,160 | 4,391 | $2.7M | $382,962 |
| 2022 | 32 | 2,864 | 4,010 | $2.2M | $335,441 |
| 2021 | 27 | 2,475 | 3,188 | $1.4M | $219,729 |
| 2020 | 31 | 1,910 | 2,549 | $1.0M | $182,856 |
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 484 | 863 | $270,982 | $78,921 | 29.1% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 17 | 37 | $442,908 | $53,652 | 12.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 150 | 150 | $526,350 | $52,626 | 10.0% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 11 | 11 | $292,974 | $38,750 | 13.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 261 | 266 | $388,626 | $37,639 | 9.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 114 | 456 | $96,672 | $19,473 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 142 | 142 | $68,586 | $16,718 | 24.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 51 | 67 | $68,876 | $9,662 | 14.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 166 | 169 | $68,614 | $8,370 | 12.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 15 | 18 | $43,290 | $8,297 | 19.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 37 | 40 | $52,400 | $7,567 | 14.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 134 | 268 | $9,403 | $6,577 | 69.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 62 | $24,862 | $6,328 | 25.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 41 | 42 | $42,126 | $6,176 | 14.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 94 | 94 | $65,800 | $4,800 | 7.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 396 | 443 | $55,818 | $4,562 | 8.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 541 | 680 | $34,000 | $4,308 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 35 | $7,420 | $2,062 | 27.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 32 | 96 | $11,520 | $1,998 | 17.3% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 12 | 19 | $12,920 | $1,842 | 14.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 17 | $5,134 | $1,634 | 31.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 52 | 73 | $10,877 | $1,609 | 14.8% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 30 | 36 | $6,300 | $1,489 | 23.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 23 | 23 | $11,132 | $1,254 | 11.3% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 15 | 16 | $7,216 | $1,052 | 14.6% |
About Dr. Maged Amine, MD
Dr. Maged Amine, MD is a Cardiovascular Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639161011.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maged Amine, MD has received a total of $62,225 in payments from pharmaceutical and medical device companies, with $4,674 received in 2024. These payments were reported across 784 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($25,436).
As a Medicare-enrolled provider, Amine has provided services to 10,409 Medicare beneficiaries, totaling 14,138 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Houston, TX
- Active Since 08/22/2005
- Last Updated 07/28/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639161011
Products in Payments
- ENTRESTO (Drug) $15,858
- KENGREAL (Drug) $7,157
- Reveal LINQ (Device) $2,808
- Impella (Device) $2,085
- Resolute (Device) $2,066
- OPTIS (Device) $1,593
- CARDIOMEMS (Device) $1,331
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,240
- ZONTIVITY (Drug) $1,180
- BPV-Crosser Catheter (Device) $942.55
- CVX-300CVX-300P (Device) $875.97
- OPTIMIZER (Device) $874.38
- Repatha (Biological) $791.54
- CARTO 3 (Device) $664.22
- Optimizer (Device) $627.39
- Aggrastat (tirofiban HCl) (Drug) $601.82
- LEQVIO (Drug) $511.89
- CardioMEMS HF System (Device) $510.64
- XARELTO (Drug) $497.48
- GALLANT (Device) $479.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Houston
Reynolds Delgado, M.d, M.D
Cardiovascular Disease — Payments: $600,466
Dr. Miguel Valderrabano, Md, MD
Cardiovascular Disease — Payments: $471,736
Asif Ali, Md, MD
Cardiovascular Disease — Payments: $461,190
Mr. Mehdi Razavi, Md, MD
Cardiovascular Disease — Payments: $433,792
Dr. Michele Sartori, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Barry Trachtenberg, Md, MD
Cardiovascular Disease — Payments: $273,547